The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
For full access to this article login to GEN Select now.
LC Applications Are Expanding
Range of Approaches in Life Sciences to Be Addressed at “Pittcon 2008”
- A tremendously useful tool for characterizing biotherapeutics is LC/MS of intact mAbs. Scott Berger, Ph.D., a principal scientist in the biopharmaceutical sciences group at Waters , will tackle this topic at the annual “Pittcon” conference in New Orleans next month. A number of other speakers will also focus on ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.